Altium Capital
North America, New York, United States, New York
Description
Altium Capital is a healthcare investment firm focusing on the development of stage public mid-and small-cap equities.
Investor Profile
Altium Capital has backed more than 18 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 6% of its total and boasts 13 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity, Series B, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, Canada, Australia.
- Strong thematic focus on Biotechnology, Therapeutics, Health Care.
Stage Focus
- Post Ipo Equity (56%)
- Series B (11%)
- Series Unknown (11%)
- Series D (6%)
- Seed (6%)
- Series C (6%)
- Series A (6%)
Country Focus
- United States (72%)
- Canada (11%)
- Australia (11%)
'/%3e%3c/defs%3e%3cpath fill='%23012169' d='M0 0h10080v5040H0z'/%3e%3cpath stroke='%23fff' stroke-width='.6' d='m0 0 6 3m0-3L0 3' clip-path='url(%23b)' transform='scale(840)'/%3e%3cpath stroke='%23e4002b' stroke-width='.4' d='m0 0 6 3m0-3L0 3' clip-path='url(%23c)' transform='scale(840)'/%3e%3cpath stroke='%23fff' stroke-width='840' d='M2520 0v2520M0 1260h5040'/%3e%3cpath stroke='%23e4002b' stroke-width='504' d='M2520 0v2520M0 1260h5040'/%3e%3cg fill='%23fff'%3e%3cuse xlink:href='%23d' x='2520' y='3780'/%3e%3cuse xlink:href='%23a' x='7560' y='4200'/%3e%3cuse xlink:href='%23a' x='6300' y='2205'/%3e%3cuse xlink:href='%23a' x='7560' y='840'/%3e%3cuse xlink:href='%23a' x='8680' y='1869'/%3e%3cuse xlink:href='%23e' x='8064' y='2730'/%3e%3c/g%3e%3c/svg%3e)
- Israel (6%)
Industry Focus
- Biotechnology
- Therapeutics
- Health Care
- Biopharma
- Pharmaceutical
- Life Science
- Medical
- Genetics
- Clinical Trials
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
